Introduction {#S1}
============

Gastric ulcers, also known as peptic ulcers, develop within the epithelial lining of the stomach due to the reduction of the mucus layer by the enhanced secretion of acid and pepsin. Some of the main contributing factors to these erosion processes within the stomach are *Helicobacter pylori* infection, abuse of alcohol, smoking, or the prolonged use of non-steroidal anti-inflammatory drugs (NSAIDs) ([@B49]). According to the systematic review on the global incidence of peptic ulcers by [@B3], South Korea has one of the highest annual incidences of perforated peptic ulcers in the 21^st^ century. The clinical approaches for treatment are still limited to proton pump inhibitors or the eradication of *H. pylori*, that includes antibiotic therapy. Most of the recommended drugs, such as the proton pump inhibitors prevent gastric ulcers through the suppression of acid production within the stomach, disrupting the protective pH barrier which promotes a higher risk of enteric infections caused by bacterial pathogens such as *Clostridium difficile*, *Salmonella* spp. and *Campylobacter* spp. ([@B25]). Therefore, other alternative remedies are needed to counteract gastric ulcers by also protecting the gut from enteric infections.

Different strains of the lactic acid bacteria (LAB), and particularly some *Lactobacillus* spp., are representing some of the most commonly used probiotics, defined as "live microorganisms which, when administered in adequate amounts, confer a health benefit on the host" ([@B17]). Extensive research has been performed on the efficacy of various *Lactobacillus* strains on gastric ulcers ([@B13]; [@B27]) either as single therapeutic agents or in combination with antibiotics ([@B6]; [@B20]). The majority of the investigated strains have been shown to inhibit or protect the gastric mucosal barrier through the up-regulation of prostaglandin E2 ([@B50]; [@B23]; [@B29]; [@B51]), enhancement of mucus secretion ([@B22]) or the regulation of inflammatory responses ([@B28]; [@B45]). Moreover, not only do these probiotics have prophylactic effects, but some of them also exert therapeutic effects through the enhancement of epithelial growth ([@B46]), promotion of angiogenesis ([@B13]) and up-regulation effect on anti-inflammatory cytokines expression ([@B52]). Currently, approaches involving therapies either with "new" antimicrobials and/or probiotics are considered promising approaches for therapeutics or prophylactics of gastric ulcers ([@B20]).

Several studies suggest that possible underlying mechanisms for the effect of probiotics on the host physiology may be related to their modulating role on the gut microbiota ([@B11]; [@B18]; [@B21]; [@B41]; [@B26]). Yet, a deeper understanding of the impact of probiotic administration on ameliorating gastric ulcers is still lacking and needs further investigation and better understanding. Current knowledge is suggesting that butyrate, one of the three major short chain fatty acids (SCFAs) produced by the intestinal microbiota, has a protective effect against ethanol-induced gastric ulcer formation. Pre-treatment with butyrate down-regulated the pro-inflammatory cytokines IL1β, TNFα, and IL6 and enhanced the gastric wall mucus ([@B32]). Furthermore, a butyrate-producing *Clostridium butyricum* showed a similar effect as sodium butyrate in the alcohol induced gastric ulcer model and also alleviated the gastric mucosal damage and inflammation within the cold stress model and the pyloric induction model ([@B53]). A recent publication also demonstrated the protective effect of acetate against ethanol-induced acute gastric ulcers through the regulation of inflammation in the gastric mucosa ([@B33]). Even when the efficacy of probiotics, butyrate-producing species and short chain fatty acids on gastric erosion has been reported ([@B53]; [@B33]), data obtained in studies on the relationship between these administrations and the modulation of the gut microbiota in alcohol erosion models need further critical assessment in support of a better understanding on protective processes.

Probiotics are known to modulate the gut microbiota which may in turn regulate the production of the SCFAs within the gut. Therefore, in this study we explored the efficacy of *Lb. plantarum* APSulloc 331261 GTB1^TM^ by focusing on the production of SCFAs derived from the modulation of the gut microbiota in alcohol induced gastric ulcers.

Materials and Methods {#S2}
=====================

Bacterial Culture Condition {#S2.SS1}
---------------------------

*Lactobacillus plantarum* APSulloc 331261, isolated from green tea (Dolsongi tea field, Jeju island, South Korea) was provided by Amore Pacific (KCCM11179P), and its safety and beneficial properties were described previously ([@B2]). Recently, the designation of this strain has been amended with its trademark (GTB1^TM^), and further reference to this strain (*Lactobacillus plantarum* APSulloc 331261 GTB1^TM^), will be as GTB1^TM^. *Lb. plantarum* 299v is a commercial probiotic strain that has been investigated widely for its beneficial physiological functions, amongst others for improving irritable bowel syndrome ([@B14]). The *Lb. plantarum* strains (GTB1^TM^ and 299v) were cultured at 37°C for 18 h and prepared on a daily basis in MRS broth (Difco Laboratories Inc., Franklin Lakes, NJ, United States). Bacterial cell suspensions for experimental purposes were obtained by centrifugation of overnight cultures (12,000 × *g* for 1 min at 4°C), the pellet was washed twice with sterile PBS (1x, pH 7.4, Lonza^TM^BioWhittaker^TM^, Walkersville, MD, United States) and re-suspended in PBS to match the concentration of 1 × 10^9^CFU per 200 μL of PBS before administration to the mice.

*Helicobacter pylori* SS1 (HpKTCC), used to induce a pyloric infection in murine models, was grown on Brucella broth (MBcell, Seoul, South Korea), supplemented with 1.5% agar mixed with 10% bovine serum at 37°C in presence of 5% CO~2~ with high humidity and sub-cultured every 2∼3 days (Panasonic Incubator, Osaka, Japan).

Murine Models {#S2.SS2}
-------------

All procedures carried out in the animal study were approved by the Animal Ethical Committee of Handong Global University, South Korea (20160616-007). Four-week-old, specific pathogen free (SPF), Institute for Cancer Research (ICR) male mice obtained from Saeronbio Inc. (Gyeonggi-do, South Korea) were provided with sterilized water and normal chow diet (Purina, Chicago, IL, United States) at *ad libitum* and housed under 23°C ± 1°C and 55 ± 10% humidity in a 12 h light/dark cycle.

Alcohol Induced GU Murine Model {#S2.SS3}
-------------------------------

All the mice were adapted in the set environment for 1 week and then randomized into five groups (*n* = 8) as described: Group A -- PBS (control group without ethanol induction); Group B -- EtOH (control group with ethanol induction); Group C -- AP (*Lb. plantarum* APSulloc 331261 GTB1^TM^); Group D -- 299v (probiotic control, *Lb. plantarum* 299v); Group E -- OMPZ (most commonly used proton pump inhibitor drug control, Omeprazole).

The probiotics groups, receiving GTB1^TM^ and *Lb. plantarum* 299v, respectively, were pretreated with 1 × 10^9^ CFU/day, for 7 days before ethanol induction, while the omeprazole group was fed with 13 mg/kg body weight/day of omeprazole according to the dose applied by [@B53], for the same period. After the pre-treatments, the alcohol induced GU model was prepared and performed according to [@B32] on 8 days and the mice were sacrificed 1 h after the induction. Part of the gastric tissue was fixated in 4% formaldehyde for histological assessment and the serum, cecum, liver, and stomach were collected and stored at −80°C until further analysis.

Ethanol Erosion and *H. pylori* Infection Murine Model {#S2.SS4}
------------------------------------------------------

Following the initial induction with ethanol and *H. pylori* infection, the groups received the probiotic strains (*Lb. plantarum* GTB1^TM^ and 299v) and the drug Omeprazole as control; sacrifice followed 2 weeks later. The 60% ethanol was fed orally to the pre-treatment and post-treatment groups 3 h prior to *H. pylori* infection by re-suspending 2 × 10^9^ CFU/mL PBS and administering 0.5 mL to each animal according to [@B31]. All mice were sacrificed 2 weeks after the ethanol induction and *H. pylori* infection. Part of the gastric tissue was fixed in 4% formaldehyde for histological assessment and the serum, cecum, liver, and stomach were collected and stored at −80°C until further analysis.

H&E Staining of Gastric Tissue {#S2.SS5}
------------------------------

The paraffin blocks of the gastric tissues fixed in 4% formaldehyde were analyzed by the Korea Experimental Pathology Inc. (Gwangju-si, Gyeonggi-do, South Korea). These tissues were sectioned into 7 μm thick specimens and stained with hematoxylin and eosin (H&E). Observations were made under a light microscope to determine levels of pathological damage. The tissues were blindly scored according to gastric mucosal injury and neutrophil infiltration at a scale of 0--4 provided by [@B16].

RNA Extraction and qRT-PCR Analysis {#S2.SS6}
-----------------------------------

Gastric tissue was homogenized in 1 mL of TRIzol^TM^ Reagent (Invitrogen^TM^, Thermo Fisher Scientific, San Diego, CA, United States) and RNA extracted according to the manufacture's protocol. SPECTROstar Nano (BMG Labtech, Offenburg, Germany) was used to evaluate the RNA concentration and purity. Two micrograms of complementary DNA were prepared using the GoScript^TM^ Reverse Transcription System (Promega, Madison, WI, United States) and 5 min incubation with oligo-dT primer at 70°C on the Verity 96-well thermal cycler (Applied Biosystems, Foster City, CA, United States). Specific primers for analyzing gastric cytokines ([Supplementary Table S1](#TS1){ref-type="supplementary-material"}), SYBR green Premix Ex Taq^TM^ II (Takara, Shiga, Japan) and 20 ng of cDNA were mixed for each reaction using the Step-One Plus real-time PCR system (Applied Biosystems) for quantitative real-time PCR analysis according to [@B41].

Cecal Short Chain Fatty Acid (SCFA) Detection {#S2.SS7}
---------------------------------------------

The SCFAs, obtained from 40 mg of cecal content, were mixed with 150 μL of extraction buffer formulated according to [@B44] and lysed for 3 min in a Mini-Beadbeater-16 (BioSpec Products, Bartlesville, OK, United States). The mixture was incubated in a horizontal shaker at 25°C for 1 h and then centrifuged at 16,000 × *g* and 25°C for 5 min. The supernatant was carefully transferred into a 9 mm blue screw-capped clear glass vial with interlock insert (Agilent Technologies, Palo Alto, CA, United States). Volatile Free Acid Mix (Supelco, 46975-U, Sigma-Aldrich, St. Louis, MO, United States) was used to create a standard curve for the quantification of the cecal SCFAs that were detected using gas chromatography (Shimadzu GC2010, Shimadzu, Kyoto, Japan).

Cecum DNA Extraction and qRT-PCR Analysis {#S2.SS8}
-----------------------------------------

DNA was extracted by using the QIAmp DNA mini-kit (Qiagen, Valencia, CA, United States). 50 mg of the cecum were mixed with 0.3 g of 0.1 mm sterile zirconia beads with 700 μL of ASL Buffer (Qiagen) in a 2 mL bead beating tube and homogenized for 3 min in the Mini-Beadbeater-16. The following DNA extraction procedures were performed according to the QIAmp DNA Mini Kit manufacturer's instructions. Microbiota analysis of the supplementary model was performed by qRT-PCR and using the specific primers suggested by [@B5].

Cecum Library Preparation and Microbiota Analysis {#S2.SS9}
-------------------------------------------------

Cecal genomic DNA was diluted with 10 mM Tris--HCl pH 8.5 buffer to 5 ng/μL prepared according to the Illumina 16S metagenomics sequencing library protocol. The 16S rRNA V3-V4 region was amplified using the following amplicon primers: 16S Amplicon PCR Forward Primer 5′TCG TCG GCA GCG TCA GAT GTG TAT AAG AGA CAG CCT ACG GGN GGC WGC AG′3 and 16S Amplicon PCR Reverse Primer 5'GTC TCG TGG GCT CGG AGA TGT GTA TAA GAG ACA GGA CTA CHV GGG TAT CTA ATC C′3.

The amplified samples with linker primers were then barcoded using the dual indexing method involving the Nextera XT kit (Illumina, San Diego, CA, United States). The final products were normalized and pooled using PicoGreen, and the size of libraries were verified using the LabChip GX HT DNA High Sensitivity Kit (PerkinElmer, Waltham, MA, United States) and performed on an Illumina Miseq platform.

The barcode, linker, and primer sequences were then removed from the original sequencing reads and were replaced with sample names. The removed reads were then merged by their paired-ends using FLASH v 1.2.11. The merged reads containing two or more ambiguous nucleotides, those with a low-quality score (average score \< 20), and reads shorter than 300 base pairs, were filtered out. Potential chimeric sequences were detected using the Bellerophon method. The pre-processed reads from each sample were used to calculate the number of operational taxonomic units (OTUs). The number of OTUs was determined by clustering the sequences from each sample using a 97% sequence identity cut-off and the taxonomic profiling and diversity of each group were analyzed and visualized using macQIIME software (v.1.9.1).

Statistics {#S2.SS10}
----------

All values are expressed as mean ± SD. Statistical differences were determined by one-way ANOVA using Fisher's Least Significant Difference (LSD). A *p*-value less than 0.05 was considered statistically significant.

Results {#S3}
=======

Efficacy of *Lb. plantarum* APSulloc 331261 GTB1^TM^ Against Alcohol Induced Gastric Ulcer {#S3.SS1}
------------------------------------------------------------------------------------------

The visual damage shown from the gross morphology of the gastric mucosa was significantly different in the GTB1^TM^ treated group (AP) after the induction with alcohol, and showed lower impairment of hemorrhaging gastric tissue ([Figure 1A](#F1){ref-type="fig"}). Furthermore, histological staining revealed less mucosal tissue damage while the pathological score in the AP fed group was significantly lower than that of the ethanol induced (EtOH) group ([Figures 1B,C](#F1){ref-type="fig"}).

![Effects of *Lactobacillus plantarum* APSulloc 331261 GTB1^TM^ on the macroscopic morphology, and histological assessment of acute gastric injuries of the gastric mucosa of ethanol challenged mice. **(A)** Gross morphology of the gastric mucosa of mice challenged with ethanol, **(B)** H+E staining of the gastric mucosa, **(C)** pathological analysis of the gastric mucosal histology. PBS: non-ethanol treated group, EtOH: ethanol treated control group, OMPZ: omeprazole treated group, 299v: *Lactobacillus plantarum* 299v, AP: *Lactobacillus plantarum* APSulloc 331261 GTB1^TM^. \*\**p* \< 0.01, \*\*\**p* \< 0.005.](fmicb-11-00420-g001){#F1}

Expression of Inflammatory Cytokines in Alcohol Induced Gastric Tissue {#S3.SS2}
----------------------------------------------------------------------

There was no significant difference in the AP (GTB1^TM^) group compared to the EtOH group in the expression levels, neither of the anti-inflammatory cytokine interleukin 10 (IL10) nor the pro-inflammatory cytokine interleukin (IL6) ([Figures 2A,B](#F2){ref-type="fig"}). However, the ratio of IL6/IL10 showed a significant difference with the EtOH group in both the non-treated PBS control and AP (GTB1^TM^) groups ([Figure 2C](#F2){ref-type="fig"}). Furthermore, in the study of the *H. pylori* infected mice after erosion of the gastric mucosa through alcohol induction, the inflammatory cytokines tumor necrosis factor alpha (TNF-α), interleukin 1 beta (IL1β) and interleukin 4 (IL4) were significantly down-regulated in the GTB1^TM^ treated mice when compared to the HP control (*H. pylori* infected) group and, with the exception of TNF-α, also the 299v group ([Supplementary Figure S1](#FS1){ref-type="supplementary-material"}).

![The effect of *Lactobacillus plantarum* APSulloc 331261 GTB1^TM^ on IL10 and IL6 levels in gastric tissue of the ethanol induced GU mice model **(A)** expression of interleukin 10 (IL10) **(B)** expression of interleukin 6 (IL6) **(C)** IL6/IL10 ratio. PBS: non-ethanol treated group, EtOH: ethanol treated control group, OMPZ: omeprazole treated group, 299v: *Lactobacillus plantarum* 299v, AP: *Lactobacillus plantarum* APSulloc 331261 GTB1^TM^. Data was analyzed with one-way-ANOVA compared to EtOH \**p* \< 0.05, \*\**p* \< 0.01.](fmicb-11-00420-g002){#F2}

Effects of *Lb. plantarum* APSulloc 331261 on SCFA Production {#S3.SS3}
-------------------------------------------------------------

While no significant difference in the production of the SCFAs acetate, propionate and butyrate could be detected between the positive control (EtOH treated group) and the two LAB treated groups, OMPZ treatment resulted in a significant decrease in each of the three SCFAs ([Figures 3A--C](#F3){ref-type="fig"}) and the total SCFAs ([Figure 3D](#F3){ref-type="fig"}). On the other hand, a significant decrease was recorded in the acetate/propionate ratio in the LAB treated and the omeprazole drug control (OMPZ) groups ([Figure 3E](#F3){ref-type="fig"}) and also in the acetate/butyrate ratio ([Figure 3F](#F3){ref-type="fig"}). Moreover, in the study on the *H. pylori* infected mice, all three SCFAs significantly increased only in the post-treatment GTB1^TM^ and OMPZ groups after erosion of the gastric mucosa through alcohol induction ([Supplementary Figure S2](#FS2){ref-type="supplementary-material"}).

![Short chain fatty acids (SCFA) in the ethanol treated mouse cecum: **(A)** acetate **(B)** propionate **(C)** butyrate **(D)** total SCFA **(E)** ratio of acetate/propionate **(F)** ratio of acetate/butyrate. PBS: non-ethanol treated group, EtOH: ethanol treated control group, OMPZ: omeprazole treated group, 299v: *Lactobacillus plantarum* 299v, AP: *Lactobacillus plantarum* APSulloc 331261 GTB1^TM^. Data was analyzed with student's *t*-test and compared to EtOH treatment; \**p* \< 0.05, \*\**p* \< 0.01.](fmicb-11-00420-g003){#F3}

Modulation of the Gut Microbiota Through the Administration of *Lb. plantarum* APSulloc 331261 GTB1^TM^ {#S3.SS4}
-------------------------------------------------------------------------------------------------------

The administration of GTB1^TM^ induced significant changes in the structure of the gut microbiota and the ratio among bacterial groups. Both the un-weighted and weighted beta diversity showed a significant shift in the microbial community when compared to the alcohol-induced (EtOH) control ([Figures 4D,E](#F4){ref-type="fig"}). A clear distinction between the microbial communities is shown across the PC1 of the un-weighted principle coordinate analysis (PCoA) plot ([Figure 4D](#F4){ref-type="fig"}) and PC1 and PC2 of the weighted PCoA plot ([Figure 4E](#F4){ref-type="fig"}). Furthermore, the AP group showed significantly higher richness in alpha diversity (Chao 1 and observed OTUs) but lower evenness (Shannon diversity) compared to the EtOH control group ([Figures 4A--C](#F4){ref-type="fig"}). At the genus level there was a significant increase of *Akkermansia* in the AP group compared to the EtOH group, while in the family *Ruminococcaceae* one genus was significantly decreased in the AP group ([Figure 5](#F5){ref-type="fig"}). It is also noteworthy that, compared to all other groups, administration of GTB1^TM^ resulted in a significant increase in abundance of both *Bifidobacterium* spp. and *Clostridium butyricum*. More detailed information on modulation of the gut microbiota resulting from the different treatments is shown in [Supplementary Figure S3](#FS3){ref-type="supplementary-material"}.

![Alpha and beta diversity of cecal microbiota from ethanol treated mice: **(A)** Chao 1, **(B)** Observed OTUs, **(C)** Shannon Diversity, **(D)** unweighted beta-diversity principal coordinates analysis and value of PC1 and PC2 principle coordinate dimensions, and **(E)** weighted beta- diversity principal coordinates analysis and value of PC2 and PC3 principle coordinate dimensions. PBS: non-ethanol treated group, EtOH: ethanol treated control group, OMPZ: omeprazole treated group, 299v: *Lactobacillus plantarum* 299v, AP: *Lactobacillus plantarum* APSulloc GTB1^TM^. Data was analyzed with one-way-ANOVA compared to EtOH \**p* \< 0.05, \*\**p* \< 0.01.](fmicb-11-00420-g004){#F4}

![Taxonomic analysis of cecal microbiota from ethanol treated mice: **(A)** relative abundance of the genus level taxonomic composition, and **(B)** relative abundance of the genera *Akkermansia* and *Ruminococcus.* PBS: non-ethanol treated group, EtOH: ethanol treated control group, OMPZ: omemprazole treated group, 299v: *Lactobacillus plantarum* 299v, AP: *Lactobacillus plantarum* APSulloc GTB1^TM^. Data was analyzed with one-way-ANOVA compared to EtOH \**p* \< 0.05, \*\**p* \< 0.01.](fmicb-11-00420-g005){#F5}

Discussion {#S4}
==========

Overconsumption of alcohol is known to impair the gastric mucosal barrier causing extensive hemorrhagic injuries, accumulate oxidative stress and increase inflammation through the production of cytokines such as IL1β, IL6, and TNF-α ([@B33]). The excessive use of alcohol not only causes organ dysfunction and health problems, but also disrupts the stability of the intestinal microbiome, resulting in what is generally known as dysbiosis ([@B15]). Some cases of microbial dysbiosis were associated with a decrease of *Verrucomicrobiae* and *Bacteriodes* and an increase in *Gammaproteobacteria* and *Bacilli* in alcoholics ([@B9]; [@B40]). In alcohol induced dysbiotic mice the *Proteobacteria* and *Actinobacteria* populations increased and were contrasted by a decrease in *Bacteroidetes*. On the other hand, the treatment of probiotics induced a shift in the three phyla in the opposite direction ([@B7]). Furthermore, beneficial effects through the direct consumption of SCFAs, known as microbial by-products, have previously been proved effective in alcohol induced murine models ([@B32], [@B33]). In pilot studies several attempts have been made for the direct delivery of SCFAs as postbiotic, either via enemas or orally through a pH-dependent slow release mechanism. However, the results have been inconsistent thus far, and further research with a larger control group is required ([@B19]). It has been clearly established that short chain fatty acids are produced mainly in the colon as a result of microbial metabolism of non-digestible carbohydrates ([@B1]). *Lactobacillus* and *Bifidobacterium*, the main genera used as probiotics, have been shown to produce acetate *in vitro*, however, they were not able to produce propionate and butyrate as primary metabolites. However, the administration of these common probiotics may stimulate the short chain fatty acid production of other colon bacteria through generating pyruvate and lactate from the dietary carbohydrates ([@B30]). Moreover, probiotics, prebiotics and/or synbiotics can modulate the gut microbiota, and thereby inhibit pathogens and promote the growth of SCFA producing bacteria such as the propionate-producing genera *Bacteriodes, Akkermansia* and butyrate-producing genera such as *Clostridium*, *Lachnospira*, *Roseburia* and several others depending on the (probiotic) strain administered and the targeted disease ([@B34]).

It was shown previously that abundance of the genus *Akkermansia* is significantly decreased in the gut after the consumption of alcohol in an alcoholic hepatitis murine model ([@B35]). Similar effects were confirmed in our experiments. The decrease in *Akkermansia* was significantly reversed by the administration of GTB1^TM^ compared to all the other control groups. Strains belonging to the genus *Akkermansia*, a member of the phylum *Verrucomicrobia*, are strictly anaerobic, oval-shaped, Gram-negative, mucin-degrading bacteria, and are highly abundant in the colon of a healthy person, comprising about 1--4% of the total population ([@B4]). *Akkermansia* is known to produce acetate ([@B12]) and propionate through the fermentation of indigestible carbohydrates by the succinate pathway ([@B43]; [@B34]). The increase of *Akkermansia* therefore may explain the increase of propionate in the AP group (animals receiving GTB1^TM^); this was indicated by the significant decrease in the acetate/propionate ratio ([Figure 3E](#F3){ref-type="fig"}). There have been very few publications that suggest some corelation of *Akkermansia* with proinflammatory cytokines ([@B10]) and colorectal cancer ([@B54]). However, potential pathogenicity of *Akkermansia* has not been clearly defined. Furthermore, more studies prove that the decrease of *Akkermansia* was clearly correlated with diabetes, obesity and inflammatory bowel disease demonstrating a protective role of *Akkermansia* and also suggesting it as a promising probiotic ([@B55]). The short chain fatty acids, acetate, propionate and butyrate are produced by bacterial fermentation of indigestible carbohydrates within the gut ([@B38]). [@B33] reported that although the administration of propionate did not show attenuation of gastric erosion in the alcohol induced model, it is widely known for its immunomodulatory effects in various gastrointestinal diseases, e.g. by inhibiting pro-inflammatory cytokines such as TNF-α, IL8 and IL6 in inflammatory bowel disease ([@B48]). Apart from the gut, the production of propionate influences the host metabolic health by decreasing lipid synthesis within the liver, regulating satiety through the stimulation of leptin and glucagon-like peptide-1, and lowering serum cholesterol levels ([@B24]; [@B42]).

The GTB1^TM^ treated group showed significant differences in beta-diversity between the microbiota groups in both un-weighted and weighted PCoA plots ([Figures 4D,E](#F4){ref-type="fig"}) demonstrating a different abundance and variety of the microbial communities between each group. Compared to the EtOH control group there was also a significantly higher richness shown through chao1 and the observed OTUs (observed operational taxonomic units) ([Figures 4A,B](#F4){ref-type="fig"}) in the AP group, but a much lower evenness calculated by Shannon diversity. Also, in comparison with the EtOH control group, the richness in the non-treated PBS control group and the OMPZ group (Omeprazole treated) significantly increased ([Figure 4C](#F4){ref-type="fig"}). Loss of microbial diversity is used as one of the indicators of intestinal dysbiosis, especially in metabolic diseases caused by "Western Diet" which are typically characterized by a high amount of fat and sugar ([@B39]). The AP group (receiving GTB1^TM^) showed an increase in richness. This suggests significant changes in particular microbial communities, and thereby an overall increase in alpha diversity. A similar change was detected in the OMPZ group. On the other hand, there was only a decrease in evenness of the GTB1^TM^ group, while for all the other groups significant changes could not be detected. Although there was a higher richness in the microbial genera of the AP group, the significantly lower evenness may have been mainly due to the increased ratio of *Akkermansia* within the community ([Figure 5B](#F5){ref-type="fig"}).

Furthermore, the beneficial effects of GTB1^TM^ administration were supported by histological analysis under the light microscope showing a morphologically significant lower gastric tissue erosion level an a significantly reduced pathological score. This result was in fact comparable to that of the OMPZ group, receiving omeprazole, the most commonly used drug for gastric ulcers ([Figure 1](#F1){ref-type="fig"}). In both the GTB1^TM^ and OMPZ treated groups the production of the anti-inflammatory cytokine IL10 ([Figure 2A](#F2){ref-type="fig"}), was increased, while only in the GTB1^TM^ group a lower production of the pro-inflammatory cytokine IL6 ([Figure 2B](#F2){ref-type="fig"}) was detected. The IL6/IL10 ratio ([Figure 2C](#F2){ref-type="fig"}) in the GTB1^TM^ group was significantly reduced compared to the EtOH group. An increase in the ratio of IL6/IL10 has been associated with gastric cancer prognosis ([@B36]). Moreover, an increase in IL-6 in association with *H. pylori* pathogenicity and other peptic and duodenal ulcers has also been reported ([@B47]; [@B8]; [@B37]).

In this study, we observed the preventive effects in ameliorating alcohol induced gastric erosion through the pretreatment with GTB1^TM^. This pretreatment modulated the gut microbiota by increasing the diversity of the microbial community and the abundance of *Akkermansia* within the gut which in turn increased the ratio of acetate/propionate. The administration of GTB1^TM^ also increased the production of the anti-inflammatory cytokine IL10 concomitantly with a decrease in IL6 production and an overall lowering in the inflammation of the gastric tissue. Our study showed that *Lb. plantarum* strain GTB1^TM^ displays potential probiotic functions through the modulation of the gut microbiota and amelioration of gastric erosion in an alcohol induced murine model.
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